" class="no-js "lang="en-US"> BICO Archives - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture

Today CELLINK, A BICO Company, launched the BIO CELLX a novel system that automates 3D […]

Biosero Expands Laboratory Automation Capabilities with New Product Launches

Biosero, Inc., a BICO company, and a developer of laboratory automation solutions to orchestrate scientific […]

BICO Partners with the Center for Contemporary Sciences (CCS) to Reduce Animal Testing in Life Sciences

Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary […]

CELLINK and Nanoscribe Join Forces to Launch the Quantum X Bio, the World’s Most Accurate 3D Bioprinter

Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing […]

BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant

Today BICO, the world’s leading bio convergence company, announced partnership with Nanochon, a startup developing regenerative joint replacements. Under […]

BICO’s CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies

Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech Pharmaceutical Equipment Technology to […]

BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors

Today BICO, the world’s leading Bio Convergence company announced it has added Susan Tousi to […]

CYTENA Launches C.STATION, a Fully Automated Platform for Stable Cell Line Development to Streamline Production of Antibody and Gene Therapies

Today CYTENA, a BICO company, launched C.STATION, a new platform for fully automated stable cell line development. The […]

BICO Strengthens IP Portfolio with Patents in the United States and Sweden for 3D Bioprinting of Temperature Sensitive Bioinks

BICO, the world’s leading bio convergence company, has been granted two patents relating to the […]

  1. Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
  2. Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
  3. Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
  4. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  5. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more